Changes of colonic bacterial composition in Parkinson's disease and other neurodegenerative diseases
Open accessPublished version of a preprint
The DOI matches its Crossref record; 102 of the 103 references it cites were found in a registry or an index.
Abstract
In recent years evidence has emerged that neurodegenerative diseases (NDs) are strongly associated with the microbiome composition in the gut. Parkinson’s disease (PD) is the most intensively studied neurodegenerative disease in this context. In this review, we performed a systematic evaluation of the published literature comparing changes in colonic microbiome in PD to the ones observed in other NDs including Alzheimer’s disease (AD), multiple system atrophy (MSA), multiple sclerosis (MS), neuromyelitis optica (NMO) and amyotrophic lateral sclerosis (ALS). To enhance the comparability of different studies, only human case-control studies were included. Several studies showed an increase of Lactobacillus, Bifidobacterium, Verrucomicrobiaceae and Akkermansia in PD. A decrease of Faecalibacterium spp., Coprococcus spp., Blautia spp., Prevotella spp. and Prevotellaceae was observed in PD. On a low taxonomic resolution, like the phylum level, the changes are not disease-specific and are inconsistent. However, on a higher taxonomic resolution like genus or species level, a minor overlap was observed between PD and MSA, both alpha synucleinopathies. We show that standardization of sample collection and analysis is necessary for ensuring the reproducibility and comparability of data. We also provide evidence that assessing the microbiota composition at high taxonomic resolution reveals changes in relative abundance that may be specific to or characteristic of one disease or disease group, and might evolve discriminative power. The interactions between bacterial species and strains and the co-abundances must be investigated before assumptions about the effects of specific bacteria on the host can be made with certainty.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Akkermansia utilize mucin as a source of energy and may therefore reduce barrier function and increase exposure to more microbial substrates across the epithelial lining.44”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [44]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 1×
“There are up to 100 times more microbial genes, named the microbiome, than human genes in one individual [7].”
BackgroundKalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Human Genetics Shape the Gut Microbiome
Goodrich, J. K., Waters, J. L., Poole, A. C., Sutter, J. L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J. T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.053 · Cited by 3,164 · cited 1×
“Since the Faecalibacterium prausnitzi species include a high diversity of strains, a strain-dependent classification and investigation would improve insight into the beneficial and harmful effects on the host [79].”
BackgroundMicrobiota and SCFA in lean and overweight healthy subjects
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457
Gut microbiome alterations in Alzheimer’s disease
Vogt, N. M., Kerby, R. L., Dill-McFarland, K. A., Harding, S. J., Merluzzi, A. P., Johnson, S. C., Carlsson, C. M., Asthana, S., Zetterberg, H., Blennow, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13601-y · Cited by 2,137 · cited 2×
“Other methodical choices, like choosing between the different bead beating cell lysis instruments before metagenome analysis, influence this ratio up to threefold in favour of Bacteroides [55].”
BackgroundAre We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans
Sender, R., Fuchs, S., & Milo, R. (2016) · Cell · doi:10.1016/j.cell.2016.01.013 · Cited by 2,050
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age
Mariat, D., Firmesse, O., Levenez, F., Guimarăes, V., Sokol, H., Doré, J., Corthier, G., & Furet, J.-P. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-123 · Cited by 1,755
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683 · cited 1×
“This hypothesis is in line with the reports that alpha-synuclein aggregation starts in the enteric nervous system and not in the brain [1,3,99].”
ResultBacteria as vitamin suppliers to their host: A gut microbiota perspective
LeBlanc, J. G., Milani, C., de Giori, G. S., Sesma, F., van Sinderen, D., & Ventura, M. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2012.08.005 · Cited by 1,613 · cited 1×
“Also, Lactobacillus reuteri, another species from the Firmicutes phylum, is supposed to be capable of vitamin B12 synthesis [11].”
BackgroundThe role of gut microbiota in immune homeostasis and autoimmunity
Wu, H.-J., & Wu, E. (2012) · Gut Microbes · doi:10.4161/gmic.19320 · Cited by 1,426
Cattaneo, A., Cattane, N., Galluzzi, S., Provasi, S., Lopizzo, N., Festari, C., Ferrari, C., Guerra, U. P., Paghera, B., Muscio, C., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.019 · Cited by 1,382
Alterations of the human gut microbiome in multiple sclerosis
Jangi, S., Gandhi, R., Cox, L. M., Li, N., von Glehn, F., Yan, R., Patel, B., Mazzola, M. A., Liu, S., Glanz, B. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12015 · Cited by 1,307
Colonic bacterial composition in Parkinson's disease
Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., Mutlu, E., & Shannon, K. M. (2015) · Movement Disorders · doi:10.1002/mds.26307 · Cited by 1,281
Human colonic microbiota associated with diet, obesity and weight loss
Duncan, S. H., Lobley, G. E., Holtrop, G., Ince, J., Johnstone, A. M., Louis, P., & Flint, H. J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.155 · Cited by 1,222 · cited 1×
“It was suggested that the Firmicutes:Bacteroidetes ratio is also associated with obesity [48–51], but a causative key role for this ratio for obesity was questioned by other groups [52].”
BackgroundGut Microbiota and Metabolic Endotoxemia in Young Obese Mexican Subjects
Radilla-Vázquez, R. B., Parra-Rojas, I., Martínez-Hernández, N. E., Márquez-Sandoval, Y. F., Illades-Aguiar, B., & Castro-Alarcón, N. (2016) · Obesity Facts · doi:10.1159/000442479 · Cited by 1,196
Unger, M. M., Spiegel, J., Dillmann, K.-U., Grundmann, D., Philippeit, H., Bürmann, J., Faßbender, K., Schwiertz, A., & Schäfer, K.-H. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.08.019 · Cited by 1,159 · cited 9×
“Reference [42] [43] [34] [35] [36] [37] [38] [39] [40] [41]”
BackgroundMethodResultInfluentialAkkermansia muciniphila and its role in regulating host functions
Derrien, M., Belzer, C., & de Vos, W. M. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.02.005 · Cited by 1,044
Gut Microbiota and Extreme Longevity
Biagi, E., Franceschi, C., Rampelli, S., Severgnini, M., Ostan, R., Turroni, S., Consolandi, C., Quercia, S., Scurti, M., Monti, D., et al. (2016) · Current Biology · doi:10.1016/j.cub.2016.04.016 · Cited by 1,025 · cited 1×
“The different taxa interact, rely on and crowd out each other, leading to distinct compositions in various stages of human health and disease [15,16] and age [17,18].”
BackgroundKoliada, A., Syzenko, G., Moseiko, V., Budovska, L., Puchkov, K., Perederiy, V., Gavalko, Y., Dorofeyev, A., Romanenko, M., Tkach, S., et al. (2017) · BMC Microbiology · doi:10.1186/s12866-017-1027-1 · Cited by 1,000
Forsyth, C. B., Shannon, K. M., Kordower, J. H., Voigt, R. M., Shaikh, M., Jaglin, J. A., Estes, J. D., Dodiya, H. B., & Keshavarzian, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028032 · Cited by 974
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
Chen, J., Chia, N., Kalari, K. R., Yao, J. Z., Novotna, M., Paz Soldan, M. M., Luckey, D. H., Marietta, E. V., Jeraldo, P. R., Chen, X., et al. (2016) · Scientific Reports · doi:10.1038/srep28484 · Cited by 933
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
Holmqvist, S., Chutna, O., Bousset, L., Aldrin-Kirk, P., Li, W., Björklund, T., Wang, Z.-Y., Roybon, L., Melki, R., & Li, J.-Y. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1343-6 · Cited by 925 · cited 1×
“The gut–brain axis may be implicated in alpha synuclein-mediated pathology, which is supposed to spread from the gut to the brain [20].”
BackgroundReduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
Harach, T., Marungruang, N., Duthilleul, N., Cheatham, V., Mc Coy, K. D., Frisoni, G., Neher, J. J., Fåk, F., Jucker, M., Lasser, T., et al. (2017) · Scientific Reports · doi:10.1038/srep41802 · Cited by 901
Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., Peddada, S. D., Factor, S. A., Molho, E., Zabetian, C. P., et al. (2017) · Movement Disorders · doi:10.1002/mds.26942 · Cited by 874 · cited 6×
“Reference [42] [43] [34] [35] [36] [37] [38] [39] [40] [41]”
BackgroundResultInfluentialGut microbiome, obesity, and metabolic dysfunction
Tilg, H., & Kaser, A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58109 · Cited by 860 · cited 1×
“The different taxa interact, rely on and crowd out each other, leading to distinct compositions in various stages of human health and disease [15,16] and age [17,18].”
BackgroundMiyake, S., Kim, S., Suda, W., Oshima, K., Nakamura, M., Matsuoka, T., Chihara, N., Tomita, A., Sato, W., Kim, S.-W., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137429 · Cited by 809
Malinen, E., Rinttila, T., Kajander, K., Matto, J., Kassinen, A., Krogius, L., Saarela, M., Korpela, R., & Palva, A. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40312.x · Cited by 699
The Mucin Degrader Akkermansia muciniphila Is an Abundant Resident of the Human Intestinal Tract
Derrien, M., Collado, M. C., Ben-Amor, K., Salminen, S., & de Vos, W. M. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.01226-07 · Cited by 658 · cited 3×
“Moreover, both high colonic Akkermansia abundance and PD were shown to be negatively correlated to BMI [93].”
BackgroundInfluentialBedarf, J. R., Hildebrand, F., Coelho, L. P., Sunagawa, S., Bahram, M., Goeser, F., Bork, P., & Wüllner, U. (2017) · Genome Medicine · doi:10.1186/s13073-017-0428-y · Cited by 642
Cox, P. A., Banack, S. A., & Murch, S. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235808100 · Cited by 633
Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors
Klingelhoefer, L., & Reichmann, H. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.197 · Cited by 598
A timeline for Parkinson's disease
Hawkes, C. H., Del Tredici, K., & Braak, H. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.08.007 · Cited by 594 · cited 1×
“This hypothesis is in line with the reports that alpha-synuclein aggregation starts in the enteric nervous system and not in the brain [1,3,99].”
ResultBrain-Gut-Microbiota Axis in Parkinson’s Disease
Mulak, A. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i37.10609 · Cited by 583 · cited 1×
“The gut–brain axis is a bidirectional communication pathway comprising direct neural, endocrine and immunological mechanisms [19].”
BackgroundHeintz‐Buschart, A., Pandey, U., Wicke, T., Sixel‐Döring, F., Janzen, A., Sittig‐Wiegand, E., Trenkwalder, C., Oertel, W. H., Mollenhauer, B., & Wilmes, P. (2018) · Movement Disorders · doi:10.1002/mds.27105 · Cited by 554 · cited 5×
“However, they could not asses any of the known cyano-neurotoxins [40].”
BackgroundMethodInfluentialIntestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease
Hasegawa, S., Goto, S., Tsuji, H., Okuno, T., Asahara, T., Nomoto, K., Shibata, A., Fujisawa, Y., Minato, T., Okamoto, A., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142164 · Cited by 523
Metagenomic species profiling using universal phylogenetic marker genes
Sunagawa, S., Mende, D. R., Zeller, G., Izquierdo-Carrasco, F., Berger, S. A., Kultima, J. R., Coelho, L. P., Arumugam, M., Tap, J., Nielsen, H. B., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2693 · Cited by 516
Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease
Pistollato, F., Sumalla Cano, S., Elio, I., Masias Vergara, M., Giampieri, F., & Battino, M. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuw023 · Cited by 496 · cited 1×
“, who examined the Chamorro people of Guam, who exhibit a 50–100 times higher incidence of ALS than anywhere else [84].”
BackgroundAnalysis of Gut Microbiota in Patients with Parkinson’s Disease
Petrov, V. A., Saltykova, I. V., Zhukova, I. A., Alifirova, V. M., Zhukova, N. G., Dorofeeva, Y. B., Tyakht, A. V., Kovarsky, B. A., Alekseev, D. G., Kostryukova, E. S., et al. (2017) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-017-3700-7 · Cited by 487 · cited 14×
“Reference [42] [43] [34] [35] [36] [37] [38] [39] [40] [41]”
BackgroundResultInfluentialVagotomy and Parkinson disease: A Swedish register–based matched-cohort study
Liu, B., Fang, F., Pedersen, N. L., Tillander, A., Ludvigsson, J. F., Ekbom, A., Svenningsson, P., Chen, H., & Wirdefeldt, K. (2017) · Neurology · doi:10.1212/wnl.0000000000003961 · Cited by 447 · cited 1×
“Also, in humans, there is some evidence supporting the role of the gut–brain axis in PD pathophysiology, for example that truncal vagotomy reduces the risk for PD [21].”
Gut microbiota in multiple sclerosis: possible influence of immunomodulators
Cantarel, B. L., Waubant, E., Chehoud, C., Kuczynski, J., DeSantis, T. Z., Warrington, J., Venkatesan, A., Fraser, C. M., & Mowry, E. M. (2015) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000192 · Cited by 409 · cited 6×
“Unspec PD: [40], MS: [64] Verrucomicrobiaceae Unspec.”
ResultInfluentialProbiotics and the Gut Immune System: Indirect Regulation
La Fata, G., Weber, P., & Mohajeri, M. H. (2018) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-017-9322-6 · Cited by 407
Self-citationLi, W., Wu, X., Hu, X., Wang, T., Liang, S., Duan, Y., Jin, F., & Qin, B. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-9001-4 · Cited by 406 · cited 11×
“PD: [35], MSA: [47] MS: [67], ALS: [45], Unclassified o3= three OTU + + PD, o3: [35], NMO, o1: [58] Lachnospira, ALS: [45] Roseburia o2 = two OTU + PD: [38], +o2: [35], MS: [57] Coprococcus, e = eutactus o1 = one OTU + PD: [38], e: [34], o1: [35], NMO: [58] Blautia, g = glucerasea, p = producta o1 = one OTU + + AD: [5…”
BackgroundMethodResultInfluentialDi Rienzi, S. C., Sharon, I., Wrighton, K. C., Koren, O., Hug, L. A., Thomas, B. C., Goodrich, J. K., Bell, J. T., Spector, T. D., Banfield, J. F., et al. (2013) · eLife · doi:10.7554/elife.01102 · Cited by 404
Martín, R., Miquel, S., Benevides, L., Bridonneau, C., Robert, V., Hudault, S., Chain, F., Berteau, O., Azevedo, V., Chatel, J. M., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01226 · Cited by 398
Relationship between the gut microbiome and brain function
Mohajeri, M. H., La Fata, G., Steinert, R. E., & Weber, P. (2018) · Nutrition Reviews · doi:10.1093/nutrit/nuy009 · Cited by 376 · cited 2×
“Changes in the composition of colonic microbiota are found in PD and several other NDs [26,27].”
BackgroundSelf-citationFunctional metagenomic profiling of intestinal microbiome in extreme ageing
Rampelli, S., Candela, M., Turroni, S., Biagi, E., Collino, S., Franceschi, C., O'Toole, P. W., & Brigidi, P. (2013) · Aging · doi:10.18632/aging.100623 · Cited by 359 · cited 1×
“The different taxa interact, rely on and crowd out each other, leading to distinct compositions in various stages of human health and disease [15,16] and age [17,18].”
BackgroundCalabrese, V., Santoro, A., Monti, D., Crupi, R., Di Paola, R., Latteri, S., Cuzzocrea, S., Zappia, M., Giordano, J., Calabrese, E. J., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.10.379 · Cited by 356
Gut microbiota in early pediatric multiple sclerosis: a case−control study
Tremlett, H., Fadrosh, D. W., Faruqi, A. A., Zhu, F., Hart, J., Roalstad, S., Graves, J., Lynch, S., Waubant, E., & the US Network of Pediatric MS Centers (2016) · European Journal of Neurology · doi:10.1111/ene.13026 · Cited by 347
Varrin‐Doyer, M., Spencer, C. M., Schulze‐Topphoff, U., Nelson, P. A., Stroud, R. M., C. Cree, B. A., & Zamvil, S. S. (2012) · Annals of Neurology · doi:10.1002/ana.23651 · Cited by 341
Cyanobacterial neurotoxin BMAA in ALS and Alzheimer’s disease
Pablo, J., Banack, S. A., Cox, P. A., Johnson, T. E., Papapetropoulos, S., Bradley, W. G., Buck, A., & Mash, D. C. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01150.x · Cited by 333
Gut microbiota in Parkinson disease in a northern German cohort
Hopfner, F., Künstner, A., Müller, S. H., Künzel, S., Zeuner, K. E., Margraf, N. G., Deuschl, G., Baines, J. F., & Kuhlenbäumer, G. (2017) · Brain Research · doi:10.1016/j.brainres.2017.04.019 · Cited by 318 · cited 5×
“Reference [42] [43] [34] [35] [36] [37] [38] [39] [40] [41]”
BackgroundMethodInfluentialAndrews, Z. B., Erion, D., Beiler, R., Liu, Z.-W., Abizaid, A., Zigman, J., Elsworth, J. D., Savitt, J. M., DiMarchi, R., Tschöp, M., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3890-09.2009 · Cited by 289 · cited 2×
“Ghrelin is a gut hormone that may contribute to the maintenance and protection of normal nigrostriatal dopamine function [74].”
BackgroundTarget intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis
Zhang, Y.-G., Wu, S., Yi, J., Xia, Y., Jin, D., Zhou, J., & Sun, J. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.12.014 · Cited by 287
Ismail, N. A., Ragab, S. H., ElBaky, A. A., Shoeib, A. R. S., Alhosary, Y., & Fekry, D. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.23418 · Cited by 271
Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model
Wu, S., Yi, J., Zhang, Y.-G., Zhou, J., & Sun, J. (2015) · Physiological Reports · doi:10.14814/phy2.12356 · Cited by 267
Alzheimer's disease and the microbiome
Bhattacharjee, S., & Lukiw, W. J. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00153 · Cited by 248
Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study
Minato, T., Maeda, T., Fujisawa, Y., Tsuji, H., Nomoto, K., Ohno, K., & Hirayama, M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187307 · Cited by 248
Bahl, M. I., Bergström, A., & Licht, T. R. (2012) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2012.02523.x · Cited by 244
α-Synuclein in gut endocrine cells and its implications for Parkinson’s disease
Chandra, R., Hiniker, A., Kuo, Y.-M., Nussbaum, R. L., & Liddle, R. A. (2017) · JCI Insight · doi:10.1172/jci.insight.92295 · Cited by 236 · cited 1×
“Approximately 40% of the gut microbiome cannot be captured by reference genome-based methods [98].”
Gut microbiota: Implications in Parkinson's disease
Parashar, A., & Udayabanu, M. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.02.002 · Cited by 230
Glucuronides in the gut: Sugar-driven symbioses between microbe and host
Pellock, S. J., & Redinbo, M. R. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.767434 · Cited by 225
Gut inflammation and dysbiosis in human motor neuron disease
Rowin, J., Xia, Y., Jung, B., & Sun, J. (2017) · Physiological Reports · doi:10.14814/phy2.13443 · Cited by 224
Toll-Like Receptors: Regulators of the Immune Response in the Human Gut
Hug, H., Mohajeri, M., & La Fata, G. (2018) · Nutrients · doi:10.3390/nu10020203 · Cited by 217
Self-citationFu, Y., Ito, M., Fujita, Y., Ito, M., Ichihara, M., Masuda, A., Suzuki, Y., Maesawa, S., Kajita, Y., Hirayama, M., et al. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.02.016 · Cited by 213
Microbiota Signaling Pathways that Influence Neurologic Disease
Cox, L. M., & Weiner, H. L. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0598-8 · Cited by 207
Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms
Felice, V. D., Quigley, E. M., Sullivan, A. M., O'Keeffe, G. W., & O'Mahony, S. M. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.03.012 · Cited by 205
Fang, X., Wang, X., Yang, S., Meng, F., Wang, X., Wei, H., & Chen, T. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01479 · Cited by 205 · cited 9×
“A minority of studies in other NDs, namely two ALS studies [45,46] and one MSA study [47], discovered an aberrant Firmicutes:Bacteroides ratio, indicating no predominant role for the NDs.”
BackgroundResultInfluentialDoes Parkinson’s disease start in the gut?
Lionnet, A., Leclair-Visonneau, L., Neunlist, M., Murayama, S., Takao, M., Adler, C. H., Derkinderen, P., & Beach, T. G. (2018) · Acta Neuropathologica · doi:10.1007/s00401-017-1777-8 · Cited by 176 · cited 1×
“While some researchers question whether PD begins in the gut, a potential role of the gut microbiome in PD pathology is undisputed [4].”
BackgroundThe fecal microbiome of ALS patients
Brenner, D., Hiergeist, A., Adis, C. I., Mayer, B., Gessner, A., Ludolph, A. C., & Weishaupt, J. H. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.09.023 · Cited by 174 · cited 5×
“Also, in other neurodegenerative diseases like AD [56], MSA [47,70], MS [57,64–66,76], ALS [45,46,71] and NMO [58], no change in this phylum was reported.”
BackgroundResultInfluentialStarke Belege: Parkinson könnte im Verdauungstrakt beginnen
(2017) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-0043-113319 · Cited by 161
Pilot study of H2 therapy in Parkinson's disease: A randomized double‐blind placebo‐controlled trial
Yoritaka, A., Takanashi, M., Hirayama, M., Nakahara, T., Ohta, S., & Hattori, N. (2013) · Movement Disorders · doi:10.1002/mds.25375 · Cited by 158
Gut microbiome analysis in neuromyelitis optica reveals overabundance of Clostridium perfringens
Cree, B. A. C., Spencer, C. M., Varrin‐Doyer, M., Baranzini, S. E., & Zamvil, S. S. (2016) · Annals of Neurology · doi:10.1002/ana.24718 · Cited by 155 · cited 10×
“This reduction is in agreement with the observed reduction of the genus Clostridium in AD [56] and MS [57].”
BackgroundResultInfluentialUnusual sub-genus associations of faecal Prevotella and Bacteroides with specific dietary patterns
De Filippis, F., Pellegrini, N., Laghi, L., Gobbetti, M., & Ercolini, D. (2016) · Microbiome · doi:10.1186/s40168-016-0202-1 · Cited by 128
Enteric glial cells: New players in Parkinson's disease?
Clairembault, T., Leclair‐Visonneau, L., Neunlist, M., & Derkinderen, P. (2015) · Movement Disorders · doi:10.1002/mds.25979 · Cited by 117 · cited 1×
“Moreover, a healthy intestinal barrier function seems crucial for maintaining neurological health [22].”
BackgroundLinden, J. R., Ma, Y., Zhao, B., Harris, J. M., Rumah, K. R., Schaeren-Wiemers, N., & Vartanian, T. (2015) · mBio · doi:10.1128/mbio.02513-14 · Cited by 93
Fang, X. (2016) · International Journal of Neuroscience · doi:10.3109/00207454.2015.1096271 · Cited by 86
Health Disparities and the Microbiome
Findley, K., Williams, D. R., Grice, E. A., & Bonham, V. L. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.08.001 · Cited by 86 · cited 1×
“The different taxa interact, rely on and crowd out each other, leading to distinct compositions in various stages of human health and disease [15,16] and age [17,18].”
BackgroundThe Potential Role of Gut-Derived Inflammation in Multiple System Atrophy
Engen, P. A., Dodiya, H. B., Naqib, A., Forsyth, C. B., Green, S. J., Voigt, R. M., Kordower, J. H., Mutlu, E. A., Shannon, K. M., & Keshavarzian, A. (2017) · Journal of Parkinson’s Disease · doi:10.3233/jpd-160991 · Cited by 86 · cited 10×
“A minority of studies in other NDs, namely two ALS studies [45,46] and one MSA study [47], discovered an aberrant Firmicutes:Bacteroides ratio, indicating no predominant role for the NDs.”
BackgroundResultInfluentialNew Insights into the Diversity of the Genus Faecalibacterium
Benevides, L., Burman, S., Martin, R., Robert, V., Thomas, M., Miquel, S., Chain, F., Sokol, H., Bermudez-Humaran, L. G., Morrison, M., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01790 · Cited by 86
Linking Smoking, Coffee, Urate, and Parkinson’s Disease – A Role for Gut Microbiota?
Scheperjans, F., Pekkonen, E., Kaakkola, S., & Auvinen, P. (2015) · Journal of Parkinson’s Disease · doi:10.3233/jpd-150557 · Cited by 83 · cited 1×
“Three studies found a significant reduction of Prevotellaceae family [32,43] or the genus Prevotella [34,39].”
BackgroundThe Gut Microbiome in Neuromyelitis Optica
Zamvil, S. S., Spencer, C. M., Baranzini, S. E., & Cree, B. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0594-z · Cited by 74 · cited 2×
“These antibodies are reported to exhibit a cross-reactivity to a homologous peptide sequence within the adenosine triphosphate-binding cassette (ABC) transporter permease of Clostridium perfringens [59,60].”
BackgroundBarczynska, R., Kapusniak, J., Litwin, M., Slizewska, K., & Szalecki, M. (2016) · Plant Foods for Human Nutrition · doi:10.1007/s11130-016-0542-9 · Cited by 60
Social Influences on Prevotella and the Gut Microbiome of Young Monkeys
Amaral, W. Z., Lubach, G. R., Proctor, A., Lyte, M., Phillips, G. J., & Coe, C. L. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000454 · Cited by 53
Altered gut microbiome and metabolome in patients with multiple system atrophy
Tan, A. H., Chong, C. W., Song, S. L., Teh, C. S. J., Yap, I. K. S., Loke, M. F., Tan, Y. Q., Yong, H. S., Mahadeva, S., Lang, A. E., et al. (2018) · Movement Disorders · doi:10.1002/mds.27203 · Cited by 52
Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson’s Disease
Perez-Pardo, P., Hartog, M., Garssen, J., & Kraneveld, A. D. (2017) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-017-0129-2 · Cited by 51 · cited 1×
“This high permeability of the intestinal mucosa is known as leaky gut, since bacterial products and inflammatory mediators could pass through the gut’s mucosa and invade the blood [5].”
BackgroundMeo, F. D., Donato, S., Pardo, A. D., Maglione, V., Filosa, S., & Crispi, S. (2018) · Current Drug Metabolism · doi:10.2174/1389200219666180404094147 · Cited by 44 · cited 2×
“Changes in the composition of colonic microbiota are found in PD and several other NDs [26,27].”
BackgroundSingh, N., Hasan, S., Kumar, J., Raj, I., Pathan, A., Parmar, A., Shakil, S., Gourinath, S., & Madamwar, D. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140228114456 · Cited by 38 · cited 1×
“Also, other cyanobacterial derived neurotoxins could play a role in neurodegeneration in individuals with more permeable intestinal epithelial barrier of the GI tract, like the leaky gut observed in elderly people [87].”
BackgroundFreedman, J. C., McClane, B. A., & Uzal, F. A. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.06.006 · Cited by 33
The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis
Wicks, P. J., Rasouliyan, L., Katic, B., Nafees, B., Flood, E. M., & Sasané, R. (2016) · BMC Research Notes · doi:10.1186/s13104-016-2243-8 · Cited by 32
Sonani, R. R., Rastogi, R. P., Singh, N., Thadani, J., Patel, P. J., Kumar, J., Tiwari, A. K., Devkar, R., & Madamwar, D. (2016) · PROTOPLASMA · doi:10.1007/s00709-016-0996-5 · Cited by 31 · cited 1×
“Products of other bacteria, belong to the phylum of red algae, such as a phycoerythrin, were shown to have an ameliorating effect on AD [88,89].”
BackgroundGastrointestinal Microbial Ecology with Perspectives on Health and Disease
Gillilland, M. G., Young, V. B., & Huffnagle, G. B. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00040-3 · Cited by 29 · cited 3×
“Most gut bacteria metabolise by fermentation, since the majority of resources are derived from host-ingested carbohydrates [10].”
BackgroundInfluentialMaier, E., Anderson, R. C., & Roy, N. C. (2017) · Nutrients · doi:10.3390/nu9121349 · Cited by 29
Clostridium perfringens epsilon toxin induces permanent neuronal degeneration and behavioral changes
Morris, W. E., Goldstein, J., Redondo, L. M., Cangelosi, A., Geoghegan, P. A., Brocco, M. A., Loidl, C. F., & Fernández-Miyakawa, M. E. (2017) · Toxicon · doi:10.1016/j.toxicon.2017.02.019 · Cited by 27
Yao, W., Kang, J., Kang, L., Gao, S., Yang, H., Ji, B., Li, P., Liu, J., Xin, W., & Wang, J. (2016) · Scientific Reports · doi:10.1038/srep24162 · Cited by 26
Scheperjans, F. (2017) · Movement Disorders · doi:10.1002/mds.27197 · Cited by 22
Bead-beating artefacts in the Bacteroidetes to Firmicutes ratio of the human stool metagenome
Vebø, H. C., Karlsson, M. K., Avershina, E., Finnby, L., & Rudi, K. (2016) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2016.08.005 · Cited by 20
Cases, M., Llobet, A., Terni, B., de Aranda, I. G., Blanch, M., Doohan, B., Revill, A., Brown, A. M., Blasi, J., & Solsona, C. (2017) · eNeuro · doi:10.1523/eneuro.0051-17.2017 · Cited by 19 · cited 7×
“Christensenellaceae unspecified PD: [35] unclassified PD: [35] Christensenella, m = minuta + PD, +m: [34], MS: [67]”
InfluentialCalkwood, J., Vollmer, T. L., Fox, R. J., Zhang, R., Novas, M., Sheikh, S. I., & Viglietta, V. (2015) · International Journal of MS Care · doi:10.7224/1537-2073.2015-020 · Cited by 7 · cited 2×
“also known to be increased in constipation-type IBS and decreased in diarrhoea-type IBS [72] and the co-variable constipation was methodically and statistically treated differently in the PD studies.”
Result
Research works printed but not linked: 1
- He, Z. (2014). Microarrays, Caister Academic Press.
Cited by
Interaction Between the Microbiota, Epithelia, and Immune Cells in the Intestine
Kayama, H., Okumura, R., & Takeda, K. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-070119-115104 · Cited by 747
Role and Mechanism of Gut Microbiota in Human Disease
Chen, Y., Zhou, J., & Wang, L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.625913 · Cited by 627
Zhao, Z., Ning, J., Bao, X.-Q., Shang, M., Ma, J., Li, G., & Zhang, D. (2021) · Microbiome · doi:10.1186/s40168-021-01107-9 · Cited by 616
Facchin, S., Bertin, L., Bonazzi, E., Lorenzon, G., De Barba, C., Barberio, B., Zingone, F., Maniero, D., Scarpa, M., Ruffolo, C., et al. (2024) · Life · doi:10.3390/life14050559 · Cited by 380
“The lowered SCFAs-mediated secretion of GLP-1 may activate pro-inflammatory pathways and depressive symptoms in PD patients [210,211].”
BackgroundProbiotics, prebiotics, and postbiotics in health and disease
Ji, J., Jin, W., Liu, S., Jiao, Z., & Li, X. (2023) · MedComm · doi:10.1002/mco2.420 · Cited by 384
“51,52 Although current research presents some varied results, each bacterial group in the gut plays specific roles.”
Background
Metadata
- Authors
- Gerhardt, S., & Mohajeri, M. H.
- Affiliations
- University of Zurich (CH)
- Corresponding author
- Mohajeri, M. Hasan
- ORCID
- Mohajeri, M. Hasan
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2018-06-01
- Volume
- 10
- Issue
- 6
- Pages
- 708
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6024871
- OpenAlex
- W2800577687
- Cited by
- 298
- References
- 103
- Citations by year
- 2026: 18 · 2025: 19 · 2024: 35 · 2023: 41 · 2022: 46 · 2021: 70 · 2020: 36 · 2019: 29 · 2018: 3
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Multiple Sclerosis Society
- EU Joint Programme – Neurodegenerative Disease Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- Parkinson's disease, gut microbiota, colonic microbiota, neurodegenerative diseases, Alzheimer's disease, multiple system atrophy, multiple sclerosis, neuromyelitis optica, amyotrophic lateral sclerosis, Lactobacillus, Bifidobacterium, Akkermansia, Verrucomicrobiaceae, Faecalibacterium, Prevotella, synucleinopathies
- MeSH terms
- Gastrointestinal Microbiome, Humans, Intestinal Mucosa, Parkinson Disease, Research Design, Severity of Illness Index, Reproducibility of Results, Neuroimmunomodulation, Confounding Factors, Epidemiologic, Enteric Nervous System, Disease Progression, Evidence-Based Medicine, Neurodegenerative Diseases, Biomedical Research, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
![Figure 1 Methodical approach of systematic review due to PRISMA criteria (PRISMA criteria [33]).](https://figures.cochat.ai/paper-figures/9b939278a136418e9a3ebbc4669d8e86/changes-of-colonic-bacterial-composition-in-parkinson-s-disease-and-other-figure-1.jpg)